Efficacy and Safety of Pregabalin in an Open-label, Non-comparative, Flexible-dose Trial With Diabetic Peripheral Neuropathy or Postherpetic Neuralgia.

Trial Profile

Efficacy and Safety of Pregabalin in an Open-label, Non-comparative, Flexible-dose Trial With Diabetic Peripheral Neuropathy or Postherpetic Neuralgia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2011

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Diabetic neuropathies; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 21 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top